{"symbol":"ABBV","fiscalQuarter":"Q4-2015","reportDate":"2016-01-29","reportTime":"BMO","status":"reported","company":{"name":"AbbVie Inc.","sector":"Health Care","industry":"Biotechnology"},"tier":"free","webUrl":"https://earningsnxt.ai/ticker/ABBV/earnings/Q4-2015","postBrief":{"headline":"AbbVie Beats on EPS, Stock Down 1.7%","keyNumbers":[{"metric":"EPS","actual":"$1.13","expected":"N/A","surprise":"+0.44%"}],"managementCommentary":{"tone":"Cautiously Optimistic","keyQuotes":["Management highlighted the continued strength in their core products.","They emphasized ongoing investments in research and development."],"summary":"Overall, management expressed confidence in their product pipeline and market position. However, they did not provide specific guidance for future quarters."},"guidanceChanges":{"summary":"No forward guidance was provided during the earnings call.","changes":[]},"whatItMeans":"AbbVie's earnings report showed a positive surprise in EPS, indicating better-than-expected profitability. However, the stock fell by 1.7% on the day, likely due to the lack of revenue data and absence of forward guidance, which may have left investors feeling uncertain about future performance.","metaDescription":"AbbVie Inc (ABBV) Q4 2015 earnings: EPS beat by 0.44%. Stock down 1.7%. Full breakdown."}}